Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers April 22, 2019
Pharmacy Choice - Pharmaceutical News - Data on Dementia Described by D.E. Barnes et al (Development and validation of a brief dementia screening indicator for primary care) - April 22, 2019

Pharmacy News Article

 1/5/15 - Data on Dementia Described by D.E. Barnes et al (Development and validation of a brief dementia screening indicator for primary care)

By a News Reporter-Staff News Editor at Pain & Central Nervous System Week A new study on Dementia and Mental Illness is now available. According to news reporting from Ann Arbor, Michigan, by NewsRx journalists, research stated, "Detection of 'any cognitive impairment' is mandated as part of the Medicare annual wellness visit, but screening all patients may result in excessive false positives. We developed and validated a brief Dementia Screening Indicator using data from four large, ongoing cohort studies (the Cardiovascular Health Study [CHS]; the Framingham Heart Study [FHS]; the Health and Retirement Study [HRS]; the Sacramento Area Latino Study on Aging [SALSA]) to help clinicians identify a subgroup of high-risk patients to target for cognitive screening."

The news correspondents obtained a quote from the research, "The final Dementia Screening Indicator included age (1 point/year; ages, 65-79 years), less than 12 years of education (9 points), stroke (6 points), diabetes mellitus (3 points), body mass index less than 18.5 kg/m(2) (8 points), requiring assistance with money or medications (10 points), and depressive symptoms (6 points). Accuracy was good across the cohorts (Harrell's C statistic: CHS, 0.68; FHS, 0.77; HRS, 0.76; SALSA, 0.78)."

According to the news reporters, the research concluded: "The Dementia Screening Indicator is a simple tool that may be useful in primary care settings to identify high-risk patients to target for cognitive screening."

For more information on this research see: Development and validation of a brief dementia screening indicator for primary care. Alzheimers & Dementia, 2014;10(6):656-665. Alzheimers & Dementia can be contacted at: Elsevier Science Inc, 360 Park Ave South, New York, NY 10010-1710, USA (see also Dementia and Mental Illness).

Our news journalists report that additional information may be obtained by contacting D.E. Barnes, Vet Affairs Center Practice Management & Outcomes Re, Ann Arbor, MI, United States. Additional authors for this research include A.S. Beiser, A. Lee, K.M. Langa, A. Koyama, S.R. Preis, J. Neuhaus, R.J. McCammon, K. Yaffe, S. Seshadri, M.N. Haan and D.R. Weir.

Keywords for this news article include: Michigan, Ann Arbor, United States, Brain Diseases, North and Central America, Dementia and Mental Illness, Central Nervous System Diseases

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2015, NewsRx LLC

(c) 2015 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Apr 23: Management of Bipolar Disorder
Last Chance
Apr 24: Identifying, Targeting and Managing Chronic Renal Failure
Apr 25: COPD Update for Pharmacy Professionals
Apr 28: Pharmacy & the Opioid Crisis
Apr 29: Headache Disorders: Focus on Common Migraines & Tension Headaches
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement